Financhill
Sell
33

CMPR Quote, Financials, Valuation and Earnings

Last price:
$70.53
Seasonality move :
7.15%
Day range:
$69.98 - $70.89
52-week range:
$35.21 - $76.65
Dividend yield:
0%
P/E ratio:
54.01x
P/S ratio:
0.51x
P/B ratio:
--
Volume:
55K
Avg. volume:
175.5K
1-year change:
-4.55%
Market cap:
$1.7B
Revenue:
$3.4B
EPS (TTM):
$1.31

Analysts' Opinion

  • Consensus Rating
    Cimpress Plc has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $86.50, Cimpress Plc has an estimated upside of 22.66% from its current price of $70.52.
  • Price Target Downside
    According to analysts, the lowest downside price target is $83.00 representing 100% downside risk from its current price of $70.52.

Fair Value

  • According to the consensus of 1 analyst, Cimpress Plc has 22.66% upside to fair value with a price target of $86.50 per share.

CMPR vs. S&P 500

  • Over the past 5 trading days, Cimpress Plc has underperformed the S&P 500 by -6.59% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cimpress Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cimpress Plc has grown year-over-year revenues for 11 quarters straight. In the most recent quarter Cimpress Plc reported revenues of $863.3M.

Earnings Growth

  • Cimpress Plc has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cimpress Plc reported earnings per share of $0.30.
Enterprise value:
3.3B
EV / Invested capital:
2.82x
Price / LTM sales:
0.51x
EV / EBIT:
13.52x
EV / Revenue:
0.94x
PEG ratio (5yr expected):
0.12x
EV / Free cash flow:
20.45x
Price / Operating cash flow:
11.09x
Enterprise value / EBITDA:
8.51x
Gross Profit (TTM):
$1.6B
Return On Assets:
1.65%
Net Income Margin (TTM):
0.92%
Return On Equity:
--
Return On Invested Capital:
2.74%
Operating Margin:
5.71%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $3.1B $3.3B $3.5B $805M $863.3M
Gross Profit $1.4B $1.6B $1.6B $377.1M $398.5M
Operating Income $156.6M $253.4M $241.6M $39.4M $49.3M
EBITDA $318M $400.8M $383.8M $75M $85.9M
Diluted EPS -$5.95 $5.82 $1.31 -$0.50 $0.30
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $574.1M $579.3M $443.9M $427.9M $489.3M
Total Assets $2.2B $2.1B $1.8B $1.9B $2B
Current Liabilities $663.2M $671.6M $639.2M $670.1M $754.6M
Total Liabilities $2.6B $2.5B $2.4B $2.4B $2.5B
Total Equity -$371.2M -$377.8M -$593.3M -$536.3M -$552.3M
Total Debt $1.8B $1.7B $1.7B $1.7B $1.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $203.1M $311.3M $331.7M $4.4M $25.1M
Cash From Investing -$117.2M -$69.1M -$168.4M -$25.5M -$42.8M
Cash From Financing -$108.2M -$221.9M -$116.8M -$35.4M -$14.7M
Free Cash Flow $161.2M $204M $159.8M -$27.2M -$18.6M
CMPR
Sector
Market Cap
$1.7B
$486.6M
Price % of 52-Week High
92%
80.87%
Dividend Yield
0%
0%
Shareholder Yield
4.81%
1.54%
1-Year Price Total Return
-4.55%
--
Beta (5-Year)
1.715
0.550
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $73.29
200-day SMA
Buy
Level $54.90
Bollinger Bands (100)
Buy
Level 59.97 - 69.85
Chaikin Money Flow
Sell
Level -16.2M
20-day SMA
Sell
Level $72.14
Relative Strength Index (RSI14)
Sell
Level 48.33
ADX Line
Sell
Level 17.2
Williams %R
Buy
Level -81.9407
50-day SMA
Buy
Level $68.74
MACD (12, 26)
Buy
Level 1.20
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Sell
Level -10.2M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.4021)
Sell
CA Score (Annual)
Level (-2.8746)
Buy
Beneish M-Score (Annual)
Level (-3.0944)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (11.8793)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cimpress Plc engages in web-to-print mass customization, delivering high-quality, affordable custom products quickly and conveniently even in low quantities. It operates through the following segments: Vista, PrintBrothers, Print Group, National Pen and All Other Businesses. The Vista segment consists of the operations of VistaPrint branded websites in North America, Western Europe, Australia, New Zealand, India, and Singapore. The PrintBrothers segment includes the results of druck.at, printdeal, and WIRmachenDRUCK businesses. The Print Group segment focuses on the results of Easyflyer, Exaprint, Pixartprinting, and Tradeprint businesses. The National Pen segment encompasses the global operations of nation pen business, which manufactures and markets custom writing instruments and promotional products, apparel and gifts. The All Other Buisnesses comprises of the collection of businesses grouped together based on materiality. The company was founded by Robert S. Keane in 1995 and is headquartered in Dundalk, Ireland.

Stock Forecast FAQ

In the current month, CMPR has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CMPR average analyst price target in the past 3 months is $86.50.

  • Where Will Cimpress Plc Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cimpress Plc share price will rise to $86.50 per share over the next 12 months.

  • What Do Analysts Say About Cimpress Plc?

    Analysts are divided on their view about Cimpress Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cimpress Plc is a Sell and believe this share price will drop from its current level to $83.00.

  • What Is Cimpress Plc's Price Target?

    The price target for Cimpress Plc over the next 1-year time period is forecast to be $86.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CMPR A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cimpress Plc is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of CMPR?

    You can purchase shares of Cimpress Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cimpress Plc shares.

  • What Is The Cimpress Plc Share Price Today?

    Cimpress Plc was last trading at $70.53 per share. This represents the most recent stock quote for Cimpress Plc. Yesterday, Cimpress Plc closed at $70.52 per share.

  • How To Buy Cimpress Plc Stock Online?

    In order to purchase Cimpress Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock